OXIDATIVE STRESS, ANTIOXIDANTS AND EDRF ACTION

氧化应激、抗氧化剂和 EDRF 作用

基本信息

  • 批准号:
    2734933
  • 负责人:
  • 金额:
    $ 8.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1995
  • 资助国家:
    美国
  • 起止时间:
    1995-07-01 至 2000-06-30
  • 项目状态:
    已结题

项目摘要

This proposal is based on the hypothesis that antioxidants limit the clinical manifestations of coronary artery disease in patients by preserving EDRF action. Abnormalities of EDRF action develop early in atherosclerosis and are related, in part, to excess local vascular oxidative stress and accumulation of oxidized low-density lipoprotein (LDL). Recent studies and preliminary data presented in this application strongly suggest that an imbalance between oxidative stress and antioxidant defenses in the vascular wall contribute to the development of impaired EDRF action. The overall objectives are to examine the protection afforded by the resident vascular cell content of antioxidants with respect to cell-mediated LDL oxidation, the cellular production of reactive oxygen species such as superoxide anion and hydrogen peroxide, and the preservation of EDRF action in response to oxidative insult. The primary experimental model for this proposal will be cultured bovine aortic endothelial and smooth muscle cells. The relevance of these effects for LDL oxidation in vivo will be assessed using a new model of LDL oxidation by intact arterial segments. Our research will determine the effects of these antioxidants on cellular production of reactive oxygen species such as superoxide anion and hydrogen peroxide and begin investigation into the mechanism(s) responsible for these effects. In particular, the relationship of these effects on superoxide and hydrogen peroxide production with antioxidant-mediated effects on LDL oxidation and EDRF action will be studied. We will investigate the role of vascular antioxidant content in preserving EDRF action in response to a variety of oxidative insults including reactive oxygen species and oxidized LDL. The work contained in this proposal will provide new insights into the mechanism(s) by which antioxidants provide benefit for patients with atherosclerosis. In particular, this work will help establish the role of vascular antioxidant content in the preservation of important homeostatic functions such as local vascular EDRF action.
这个提议是基于抗氧化剂限制

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John F. Keaney其他文献

Coronary artery perforation during excimer laser coronary angioplasty. The percutaneous Excimer Laser Coronary Angioplasty Registry.
准分子激光冠状动脉血管成形术期间的冠状动脉穿孔。
NADPH Oxidase 4 Promotes Endothelial Angiogenesis
  • DOI:
    10.1016/j.freeradbiomed.2010.10.018
  • 发表时间:
    2010-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Siobhan M. Craige;Kai Chen;Yongmei Pei;Xiaoyun Huang;John F. Keaney
  • 通讯作者:
    John F. Keaney
Volume-Outcome Relationship of Resternotomy Coronary Artery Bypass Grafting
  • DOI:
    10.1016/j.athoracsur.2022.09.049
  • 发表时间:
    2023-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    Nadav Rappoport;David M. Shahian;Noya Galai;Gal Aviel;John F. Keaney;Oz M. Shapira
  • 通讯作者:
    Oz M. Shapira
The Links between Mitochondrial Superoxide and Endothelial Phenotype
  • DOI:
    10.1016/j.freeradbiomed.2012.10.066
  • 发表时间:
    2012-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Ning Pan;Yukio Shimasaki;John F. Keaney
  • 通讯作者:
    John F. Keaney
Endothelial Cell AMPK Activation Induces Mitochondrial Biogenesis and Stress Adaptation via eNOS and mTOR
  • DOI:
    10.1016/j.freeradbiomed.2011.10.109
  • 发表时间:
    2011-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Chunying Li;John F. Keaney
  • 通讯作者:
    John F. Keaney

John F. Keaney的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John F. Keaney', 18)}}的其他基金

CORE--Biomarker
核心--生物标志物
  • 批准号:
    7140911
  • 财政年份:
    2006
  • 资助金额:
    $ 8.5万
  • 项目类别:
Mitochondrial Modulation of Endothelial Phenotype
内皮表型的线粒体调节
  • 批准号:
    7137141
  • 财政年份:
    2005
  • 资助金额:
    $ 8.5万
  • 项目类别:
Endothelial Redox State & Phenotype in Health & Disease
内皮氧化还原状态
  • 批准号:
    6960736
  • 财政年份:
    2005
  • 资助金额:
    $ 8.5万
  • 项目类别:
Nox Isoforms and Vascular Cell Phenotype
Nox 亚型和血管细胞表型
  • 批准号:
    7172934
  • 财政年份:
    2005
  • 资助金额:
    $ 8.5万
  • 项目类别:
Nox Isoforms and Vascular Cell Phenotype
Nox 亚型和血管细胞表型
  • 批准号:
    7014035
  • 财政年份:
    2005
  • 资助金额:
    $ 8.5万
  • 项目类别:
Nox Isoforms and Vascular Cell Phenotype
Nox 亚型和血管细胞表型
  • 批准号:
    7009478
  • 财政年份:
    2005
  • 资助金额:
    $ 8.5万
  • 项目类别:
Hypochlorite-Mediated Impairment of Endothelial Function
次氯酸盐介导的内皮功能损伤
  • 批准号:
    6851727
  • 财政年份:
    2003
  • 资助金额:
    $ 8.5万
  • 项目类别:
Hypochlorite-Mediated Impairment of Endothelial Function
次氯酸盐介导的内皮功能损伤
  • 批准号:
    7023906
  • 财政年份:
    2003
  • 资助金额:
    $ 8.5万
  • 项目类别:
Hypochlorite-Mediated Impairment of Endothelial Function
次氯酸盐介导的内皮功能损伤
  • 批准号:
    7189886
  • 财政年份:
    2003
  • 资助金额:
    $ 8.5万
  • 项目类别:
Hypochlorite-Mediated Impairment of Endothelial Function
次氯酸盐介导的内皮功能损伤
  • 批准号:
    7514533
  • 财政年份:
    2003
  • 资助金额:
    $ 8.5万
  • 项目类别:

相似海外基金

Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
  • 批准号:
    24K21101
  • 财政年份:
    2024
  • 资助金额:
    $ 8.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
  • 批准号:
    23K15842
  • 财政年份:
    2023
  • 资助金额:
    $ 8.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
  • 批准号:
    2880683
  • 财政年份:
    2023
  • 资助金额:
    $ 8.5万
  • 项目类别:
    Studentship
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
  • 批准号:
    10537602
  • 财政年份:
    2023
  • 资助金额:
    $ 8.5万
  • 项目类别:
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
  • 批准号:
    10652788
  • 财政年份:
    2023
  • 资助金额:
    $ 8.5万
  • 项目类别:
Novel Mechanisms Underlying the Development of Atherosclerosis
动脉粥样硬化发展的新机制
  • 批准号:
    10589484
  • 财政年份:
    2023
  • 资助金额:
    $ 8.5万
  • 项目类别:
Alcohol Regulation of Endothelial Plasticity in Atherosclerosis
酒精对动脉粥样硬化内皮可塑性的调节
  • 批准号:
    10585070
  • 财政年份:
    2023
  • 资助金额:
    $ 8.5万
  • 项目类别:
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
GWAS 位点从基因型到表型:REST 在动脉粥样硬化中的作用
  • 批准号:
    10570469
  • 财政年份:
    2023
  • 资助金额:
    $ 8.5万
  • 项目类别:
2023 Atherosclerosis
2023 动脉粥样硬化
  • 批准号:
    10675221
  • 财政年份:
    2023
  • 资助金额:
    $ 8.5万
  • 项目类别:
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
  • 批准号:
    10619831
  • 财政年份:
    2023
  • 资助金额:
    $ 8.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了